Ilan Ifergan

1.3k total citations
20 papers, 1.1k citations indexed

About

Ilan Ifergan is a scholar working on Oncology, Rheumatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ilan Ifergan has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Rheumatology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ilan Ifergan's work include Drug Transport and Resistance Mechanisms (10 papers), Folate and B Vitamins Research (7 papers) and Trace Elements in Health (6 papers). Ilan Ifergan is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Folate and B Vitamins Research (7 papers) and Trace Elements in Health (6 papers). Ilan Ifergan collaborates with scholars based in Israel, Netherlands and United States. Ilan Ifergan's co-authors include Yehuda G. Assaraf, Gerrit Jansen, George L. Scheffer, Alexandre Prat, Hania Kébir, Monique Bernard, Nathalie Arbour, Jan Hendrik Hooijberg, Lilah Rothem and Aurore Dodelet-Devillers and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Brain.

In The Last Decade

Ilan Ifergan

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilan Ifergan Israel 18 397 390 251 212 142 20 1.1k
Ruud Oerlemans Netherlands 13 445 1.1× 583 1.5× 153 0.6× 145 0.7× 106 0.7× 23 1.2k
Cheryl Li United States 11 189 0.5× 383 1.0× 103 0.4× 168 0.8× 60 0.4× 23 838
Krishnendu Roy United States 13 133 0.3× 762 2.0× 212 0.8× 61 0.3× 38 0.3× 24 1.1k
Vincenzo Castronovo Belgium 13 261 0.7× 393 1.0× 54 0.2× 64 0.3× 48 0.3× 27 1.0k
Kazuya Hirano Japan 18 134 0.3× 449 1.2× 57 0.2× 136 0.6× 56 0.4× 41 871
Tamotsu Miyazaki Japan 19 137 0.3× 424 1.1× 47 0.2× 311 1.5× 21 0.1× 88 1.5k
Katharine H. Dixon United States 8 333 0.8× 360 0.9× 304 1.2× 173 0.8× 98 0.7× 8 876
Kourosh Lotfi Sweden 18 264 0.7× 400 1.0× 71 0.3× 108 0.5× 41 0.3× 54 968
Shuhong Han United States 20 253 0.6× 297 0.8× 222 0.9× 549 2.6× 13 0.1× 41 1.1k

Countries citing papers authored by Ilan Ifergan

Since Specialization
Citations

This map shows the geographic impact of Ilan Ifergan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Ifergan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Ifergan more than expected).

Fields of papers citing papers by Ilan Ifergan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Ifergan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Ifergan. The network helps show where Ilan Ifergan may publish in the future.

Co-authorship network of co-authors of Ilan Ifergan

This figure shows the co-authorship network connecting the top 25 collaborators of Ilan Ifergan. A scholar is included among the top collaborators of Ilan Ifergan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilan Ifergan. Ilan Ifergan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ifergan, Ilan, Hania Kébir, Jorge I. Alvarez, et al.. (2011). Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on  4 integrin. Brain. 134(12). 3560–3577. 100 indexed citations
2.
Ifergan, Ilan, et al.. (2009). Riboflavin concentration within ABCG2-rich extracellular vesicles is a novel marker for multidrug resistance in malignant cells. Biochemical and Biophysical Research Communications. 380(1). 5–10. 19 indexed citations
3.
Ifergan, Ilan, Gerrit Jansen, & Yehuda G. Assaraf. (2008). The Reduced Folate Carrier (RFC) Is Cytotoxic to Cells under Conditions of Severe Folate Deprivation. Journal of Biological Chemistry. 283(30). 20687–20695. 40 indexed citations
4.
Ifergan, Ilan & Yehuda G. Assaraf. (2008). Chapter 4 Molecular Mechanisms of Adaptation to Folate Deficiency. Vitamins and hormones. 79. 99–143. 48 indexed citations
5.
Bram, Eran, et al.. (2007). C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells. Biochemical Pharmacology. 74(1). 41–53. 38 indexed citations
6.
Oerlemans, Ruud, B.A.C. Dijkmans, Yehuda G. Assaraf, et al.. (2007). Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor α and glucocorticoid induced apoptosis. Annals of the Rheumatic Diseases. 66(10). 1289–1295. 12 indexed citations
7.
Ifergan, Ilan, Hania Kébir, Monique Bernard, et al.. (2007). The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain. 131(3). 785–799. 149 indexed citations
8.
Oerlemans, Ruud, Ben A. C. Dijkmans, Gertjan J.L. Kaspers, et al.. (2006). Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance–associated protein 1 and provokes high levels of cross‐resistance to glucocorticoids. Arthritis & Rheumatism. 54(2). 557–568. 31 indexed citations
9.
Bram, Eran, et al.. (2006). Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates. Cancer Chemotherapy and Pharmacology. 58(6). 826–834. 29 indexed citations
10.
Assaraf, Yehuda G., et al.. (2005). Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets. Journal of Theoretical Biology. 240(4). 637–647. 13 indexed citations
11.
Ifergan, Ilan, Gerrit Jansen, & Yehuda G. Assaraf. (2005). Cytoplasmic Confinement of Breast Cancer Resistance Protein (BCRP/ABCG2) as a Novel Mechanism of Adaptation to Short-Term Folate Deprivation. Molecular Pharmacology. 67(4). 1349–1359. 32 indexed citations
12.
Ifergan, Ilan, George L. Scheffer, & Yehuda G. Assaraf. (2005). Novel Extracellular Vesicles Mediate an ABCG2-Dependent Anticancer Drug Sequestration and Resistance. Cancer Research. 65(23). 10952–10958. 95 indexed citations
13.
Kaufman, Yotam, Ilan Ifergan, Lilah Rothem, Gerrit Jansen, & Yehuda G. Assaraf. (2005). Coexistence of multiple mechanisms of PT523 resistance in human leukemia cells harboring 3 reduced folate carrier alleles: transcriptional silencing, inactivating mutations, and allele loss. Blood. 107(8). 3288–3294. 25 indexed citations
14.
Ifergan, Ilan, Eran Bram, Gerrit Jansen, et al.. (2005). ABCG2 Harboring the Gly482 Mutation Confers High-Level Resistance to Various Hydrophilic Antifolates. Cancer Research. 65(18). 8414–8422. 49 indexed citations
15.
Ifergan, Ilan, et al.. (2004). Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression. Journal of Biological Chemistry. 279(24). 25527–25534. 107 indexed citations
16.
Jansen, Gerrit, Ruud Oerlemans, Willem F. Lems, et al.. (2004). Sulfasalazine is a potent inhibitor of the reduced folate carrier: Implications for combination therapies with methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. 50(7). 2130–2139. 56 indexed citations
17.
Kaufman, Yotam, Stavit Drori, Peter D. Cole, et al.. (2004). Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia. Cancer. 100(4). 773–782. 33 indexed citations
18.
Assaraf, Yehuda G., Lilah Rothem, Jan Hendrik Hooijberg, et al.. (2003). Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia Cells. Journal of Biological Chemistry. 278(9). 6680–6686. 67 indexed citations
19.
Ifergan, Ilan, et al.. (2003). Reduced folate carrier protein expression in osteosarcoma. Cancer. 98(9). 1958–1966. 47 indexed citations
20.
Rothem, Lilah, Ilan Ifergan, Yotam Kaufman, et al.. (2002). Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines. Biochemical Journal. 367(3). 741–750. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruud Oerlemans Breakdown of academic impact, for papers by Cheryl Li Breakdown of academic impact, for papers by Krishnendu Roy Breakdown of academic impact, for papers by Vincenzo Castronovo Breakdown of academic impact, for papers by Kazuya Hirano Breakdown of academic impact, for papers by Tamotsu Miyazaki Breakdown of academic impact, for papers by Katharine H. Dixon Breakdown of academic impact, for papers by Kourosh Lotfi Breakdown of academic impact, for papers by Shuhong Han
Rankless by CCL
2026